Immunogenicity, Safety, and Tolerability of Live Attenuated VaricellaZoster Virus Vaccine (ZOSTAVAX™) in Healthy Adults in India.

Journal: The Journal of the Association of Physicians of India
Published Date: Jul 1, 2018

Abstract

BACKGROUND: Herpes zoster (HZ) is caused by varicella-zoster virus ( VZV ) reactivation. In the United States, Zoster vaccine (ZOSTAVAX) is indicated for HZ prevention in patients ≥50 years.

Authors

  • L Sreenivasamurthy
    Lifecare Clinic and Research Center, Bangalore, Karnataka;Corresponding Author.
  • Sudhanshu Pandey
    MSD, Mumbai, Maharashtra.
  • Bharija Subhash Chandra
    Department of Dermatology, Sir Ganga Ram Hospital, New Delhi.
  • Monisha Sharma
    MSD, Mumbai, Maharashtra.
  • S R Ranganathaiah
    Mysore Clinisearch, Gopal Gowda Shanthaveri Memorial Hospital Campus, Mysore, Karnataka.
  • P Vaidya
    Department of Dermatology, Jehangir Clinical Development Centre Pvt Ltd, Pune, Maharashtra.
  • Rajiv Naik
    Ketki Hospital, Aurangabad,Maharashtra.

Keywords

External Resources

Popular Topics
Recent Journals